{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:57:57Z","timestamp":1765976277069,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Amide proton transfer (APT) imaging is a novel molecular MRI technique to detect endogenous mobile proteins and peptides through chemical exchange saturation transfer. In this preliminary study, the purpose was to evaluate the feasibility of APT imaging in monitoring the early therapeutic response to nitroxoline (NTX) in a temozolomide (TMZ)-resistant glioblastoma multiforme (GBM) mouse model, which was compared with diffusion-weighted imaging (DWI). Here, we prepared TMZ-resistant GBM mouse model (<jats:italic>n<\/jats:italic>\u2009=\u200912), which were treated with 100\u2009mg\/kg\/day of NTX (<jats:italic>n<\/jats:italic>\u2009=\u20094) or TMZ (<jats:italic>n<\/jats:italic>\u2009=\u20094), or saline (<jats:italic>n<\/jats:italic>\u2009=\u20094) for 7 days for the evaluation of short-term treatment by using APT imaging and DWI sequentially. The APT signal intensities and apparent diffusion coefficient (ADC) values were calculated and compared before and after treatment. Moreover, immunohistological analysis was also employed for the correlation between APT imaging and histopathology. The association between the APT value and Ki-67 labeling index was evaluated by using simple linear regression analysis. The short-term NTX treatment resulted in significant decrease in APT value as compared to untreated and TMZ group, in which APT signals were increased. However, we did not observe significantly increased mean ADC value following short-term NTX treatment. The Ki-67 labeling index shows a correlation with APT value. APT imaging could show the earlier response to NTX treatment as compared to ADC values in a TMZ-resistant mouse model. We believe that APT imaging can be a useful imaging biomarker for the early therapeutic evaluation in GBM patients.<\/jats:p>","DOI":"10.1038\/s41598-019-42088-y","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T10:17:37Z","timestamp":1554286657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Assessment of Early Therapeutic Response to Nitroxoline in Temozolomide-Resistant Glioblastoma by Amide Proton Transfer Imaging: A Preliminary Comparative Study with Diffusion-weighted Imaging"],"prefix":"10.1038","volume":"9","author":[{"given":"Nisha","family":"Kumari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8761-0837","authenticated-orcid":false,"given":"Nishant","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Rim","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0412-2270","authenticated-orcid":false,"given":"Seung Hong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"42088_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352, 987\u2013996, https:\/\/doi.org\/10.1056\/NEJMoa043330 (2005).","journal-title":"N Engl J Med"},{"key":"42088_CR2","doi-asserted-by":"publisher","first-page":"831090","DOI":"10.1155\/2012\/831090","volume":"2012","author":"S Sengupta","year":"2012","unstructured":"Sengupta, S., Marrinan, J., Frishman, C. & Sampath, P. Impact of temozolomide on immune response during malignant glioma chemotherapy. Clin Dev Immunol 2012, 831090, https:\/\/doi.org\/10.1155\/2012\/831090 (2012).","journal-title":"Clin Dev Immunol"},{"key":"42088_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","volume":"3","author":"SY Lee","year":"2016","unstructured":"Lee, S. Y. Temozolomide resistance in glioblastoma multiforme. Genes & Diseases 3, 198\u2013210, https:\/\/doi.org\/10.1016\/j.gendis.2016.04.007 (2016).","journal-title":"Genes & Diseases"},{"key":"42088_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1586\/era.12.37","volume":"12","author":"TC Johannessen","year":"2012","unstructured":"Johannessen, T. C. & Bjerkvig, R. Molecular mechanisms of temozolomide resistance in glioblastoma multiforme. Expert Rev Anticancer Ther 12, 635\u2013642, https:\/\/doi.org\/10.1586\/era.12.37 (2012).","journal-title":"Expert Rev Anticancer Ther"},{"key":"42088_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/cancers6010226","volume":"6","author":"MM Inda","year":"2014","unstructured":"Inda, M. M., Bonavia, R. & Seoane, J. Glioblastoma multiforme: a look inside its heterogeneous nature. Cancers (Basel) 6, 226\u2013239, https:\/\/doi.org\/10.3390\/cancers6010226 (2014).","journal-title":"Cancers (Basel)"},{"key":"42088_CR6","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"DR Macdonald","year":"1990","unstructured":"Macdonald, D. R., Cascino, T. L., Schold, S. C. Jr. & Cairncross, J. G. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8, 1277\u20131280, https:\/\/doi.org\/10.1200\/JCO.1990.8.7.1277 (1990).","journal-title":"J Clin Oncol"},{"key":"42088_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-013-0347-2","volume":"13","author":"OL Chinot","year":"2013","unstructured":"Chinot, O. L. et al. Response assessment criteria for glioblastoma: practical adaptation and implementation in clinical trials of antiangiogenic therapy. Curr Neurol Neurosci Rep 13, 347, https:\/\/doi.org\/10.1007\/s11910-013-0347-2 (2013).","journal-title":"Curr Neurol Neurosci Rep"},{"key":"42088_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N. & Thompson, C. B. The Emerging Hallmarks of Cancer Metabolism. Cell Metab 23, 27\u201347, https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006 (2016).","journal-title":"Cell Metab"},{"key":"42088_CR9","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1200\/Jco.2009.25.3641","volume":"28","author":"KD Courtney","year":"2010","unstructured":"Courtney, K. D., Corcoran, R. B. & Engelman, J. A. The PI3K Pathway As Drug Target in Human Cancer. Journal of Clinical Oncology 28, 1075\u20131083, https:\/\/doi.org\/10.1200\/Jco.2009.25.3641 (2010).","journal-title":"Journal of Clinical Oncology"},{"key":"42088_CR10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/00004728-200605000-00024","volume":"30","author":"N Tomura","year":"2006","unstructured":"Tomura, N. et al. Diffusion changes in a tumor and peritumoral tissue after stereotactic irradiation for brain tumors: possible prediction of treatment response. J Comput Assist Tomogr 30, 496\u2013500 (2006).","journal-title":"J Comput Assist Tomogr"},{"key":"42088_CR11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ijrobp.2005.08.015","volume":"64","author":"A Leimgruber","year":"2006","unstructured":"Leimgruber, A. et al. Perfusion and diffusion MRI of glioblastoma progression in a four-year prospective temozolomide clinical trial. Int J Radiat Oncol Biol Phys 64, 869\u2013875, https:\/\/doi.org\/10.1016\/j.ijrobp.2005.08.015 (2006).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"42088_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11060-005-5261-2","volume":"76","author":"C Balmaceda","year":"2006","unstructured":"Balmaceda, C. et al. Multisection 1H magnetic resonance spectroscopic imaging assessment of glioma response to chemotherapy. J Neurooncol 76, 185\u2013191, https:\/\/doi.org\/10.1007\/s11060-005-5261-2 (2006).","journal-title":"J Neurooncol"},{"key":"42088_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward, P. S. & Thompson, C. B. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 21, 297\u2013308, https:\/\/doi.org\/10.1016\/j.ccr.2012.02.014 (2012).","journal-title":"Cancer Cell"},{"key":"42088_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrc2981","volume":"11","author":"RA Cairns","year":"2011","unstructured":"Cairns, R. A., Harris, I. S. & Mak, T. W. Regulation of cancer cell metabolism. Nat Rev Cancer 11, 85\u201395, https:\/\/doi.org\/10.1038\/nrc2981 (2011).","journal-title":"Nat Rev Cancer"},{"key":"42088_CR15","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/clinchem\/47.10.1901","volume":"47","author":"PR Srinivas","year":"2001","unstructured":"Srinivas, P. R., Srivastava, S., Hanash, S. & Wright, G. L. Jr. Proteomics in early detection of cancer. Clin Chem 47, 1901\u20131911 (2001).","journal-title":"Clin Chem"},{"key":"42088_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/mrm.22761","volume":"65","author":"PC van Zijl","year":"2011","unstructured":"van Zijl, P. C. & Yadav, N. N. Chemical exchange saturation transfer (CEST): what is in a name and what isn\u2019t? Magn Reson Med 65, 927\u2013948, https:\/\/doi.org\/10.1002\/mrm.22761 (2011).","journal-title":"Magn Reson Med"},{"key":"42088_CR17","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/nm907","volume":"9","author":"JY Zhou","year":"2003","unstructured":"Zhou, J. Y., Payen, J. F., Wilson, D. A., Traystman, R. J. & van Zijl, P. C. M. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 9, 1085\u20131090, https:\/\/doi.org\/10.1038\/nm907 (2003).","journal-title":"Nat Med"},{"key":"42088_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.2268","volume":"17","author":"JY Zhou","year":"2011","unstructured":"Zhou, J. Y. et al. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med 17, 130\u2013U308, https:\/\/doi.org\/10.1038\/nm.2268 (2011).","journal-title":"Nat Med"},{"key":"42088_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/neuonc\/not158","volume":"16","author":"O Togao","year":"2014","unstructured":"Togao, O. et al. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. Neuro Oncol 16, 441\u2013448, https:\/\/doi.org\/10.1093\/neuonc\/not158 (2014).","journal-title":"Neuro Oncol"},{"key":"42088_CR20","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1073\/pnas.1323855111","volume":"111","author":"K Sagiyama","year":"2014","unstructured":"Sagiyama, K. et al. In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma. Proc Natl Acad Sci USA 111, 4542\u20134547, https:\/\/doi.org\/10.1073\/pnas.1323855111 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"42088_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/neuonc\/nou139","volume":"17","author":"J Lazovic","year":"2015","unstructured":"Lazovic, J. et al. Nitroxoline induces apoptosis and slows glioma growth in vivo. Neuro-Oncology 17, 53\u201362, https:\/\/doi.org\/10.1093\/neuonc\/nou139 (2015).","journal-title":"Neuro-Oncology"},{"key":"42088_CR22","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/mrm.10651","volume":"50","author":"J Zhou","year":"2003","unstructured":"Zhou, J., Lal, B., Wilson, D. A., Laterra, J. & van Zijl, P. C. Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med 50, 1120\u20131126, https:\/\/doi.org\/10.1002\/mrm.10651 (2003).","journal-title":"Magn Reson Med"},{"key":"42088_CR23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/jmri.10395","volume":"18","author":"SK Hobbs","year":"2003","unstructured":"Hobbs, S. K. et al. Magnetic resonance image-guided proteomics of human glioblastoma multiforme. J Magn Reson Imaging 18, 530\u2013536, https:\/\/doi.org\/10.1002\/jmri.10395 (2003).","journal-title":"J Magn Reson Imaging"},{"key":"42088_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/mrm.10367","volume":"49","author":"FA Howe","year":"2003","unstructured":"Howe, F. A. et al. Metabolic profiles of human brain tumors using quantitative in vivo H-1 magnetic resonance spectroscopy. Magnet Reson Med 49, 223\u2013232, https:\/\/doi.org\/10.1002\/mrm.10367 (2003).","journal-title":"Magnet Reson Med"},{"key":"42088_CR25","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/jmri.20997","volume":"26","author":"K Tamai","year":"2007","unstructured":"Tamai, K. et al. Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 26, 682\u2013687, https:\/\/doi.org\/10.1002\/jmri.20997 (2007).","journal-title":"J Magn Reson Imaging"},{"key":"42088_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/jmri.23838","volume":"37","author":"L Sunwoo","year":"2013","unstructured":"Sunwoo, L. et al. Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme. J Magn Reson Imaging 37, 351\u2013358, https:\/\/doi.org\/10.1002\/jmri.23838 (2013).","journal-title":"J Magn Reson Imaging"},{"key":"42088_CR27","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.21873\/anticanres.11758","volume":"37","author":"A Surov","year":"2017","unstructured":"Surov, A., Meyer, H. J. & Wienke, A. Correlation Between Minimum Apparent Diffusion Coefficient (ADC(min)) and Tumor Cellularity: A Meta-analysis. Anticancer Res 37, 3807\u20133810, https:\/\/doi.org\/10.21873\/anticanres.11758 (2017).","journal-title":"Anticancer Res"},{"key":"42088_CR28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1259\/bjr\/14980811","volume":"84","author":"N Bharwani","year":"2011","unstructured":"Bharwani, N. et al. Diffusion-weighted imaging in the assessment of tumour grade in endometrial cancer. Brit J Radiol 84, 997\u20131004, https:\/\/doi.org\/10.1259\/bjr\/14980811 (2011).","journal-title":"Brit J Radiol"},{"key":"42088_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11604-007-0218-3","volume":"26","author":"MI Yoshikawa","year":"2008","unstructured":"Yoshikawa, M. I. et al. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med 26, 222\u2013226, https:\/\/doi.org\/10.1007\/s11604-007-0218-3 (2008).","journal-title":"Radiat Med"},{"key":"42088_CR30","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/mrm.21712","volume":"60","author":"J Zhou","year":"2008","unstructured":"Zhou, J. et al. Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med 60, 842\u2013849, https:\/\/doi.org\/10.1002\/mrm.21712 (2008).","journal-title":"Magn Reson Med"},{"key":"42088_CR31","doi-asserted-by":"publisher","first-page":"39759","DOI":"10.1074\/jbc.M110.147504","volume":"285","author":"CR Oliva","year":"2010","unstructured":"Oliva, C. R. et al. Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport Chain. Journal of Biological Chemistry 285, 39759\u201339767, https:\/\/doi.org\/10.1074\/jbc.M110.147504 (2010).","journal-title":"Journal of Biological Chemistry"},{"key":"42088_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1158\/1535-7163.Mct-08-0854","volume":"8","author":"MJ Clarke","year":"2009","unstructured":"Clarke, M. J. et al. Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines. Molecular Cancer Therapeutics 8, 407\u2013414, https:\/\/doi.org\/10.1158\/1535-7163.Mct-08-0854 (2009).","journal-title":"Molecular Cancer Therapeutics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42088-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:21:34Z","timestamp":1671265294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42088-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42088"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42088-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"1 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5585"}}